Determining the Effects of Risperdal Consta in Patients With Psychotic Disorders and Incomplete Adherence

Clinical trial NCT00215579 · COMPLETED

Trial details

NCT number: NCT00215579
Sponsor: Duke University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder

Start date: 2004-04-01
Primary completion: 2006-04-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.